<p>The mean IgG responses and 95% CI are shown for Indian (purple and orange lines) and Sudanese (blue and green lines) active VL patients against lysates of <i>L. donovani</i> strains isolated from Sudan [A & C] or India [B & D]. Comparative mean 1/log<sub>10</sub>t<sub>50</sub> IgG titres and fold-differences are given in <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0002675#pntd-0002675-t002" target="_blank">Table 2</a>.</p
Visceral leishmaniasis (VL) remains a major health problem in old world, and India accounts for half...
Post kala-azar dermal leishmaniasis (PKDL), a dermal sequel of visceral leishmaniasis presents with ...
<p>Sera from mucosal <i>Leishmania</i>sis (ML) (n = 53) and cutaneous <i>Leishmania</i>sis (CL) (n =...
<p>The mean IgG responses are shown with 95% CI, for 36 Indian (purple line with nodes) and 36 Sudan...
Background: Visceral leishmaniasis (VL), a widely distributed systemic disease caused by infection w...
levels in patients from different geographical regions, either due to variable antigenicity or immu...
<p>Indian and Sudanese plasma study populations used in comparative serology against <i>Leishmania d...
Sodium antimony gluconate (SAG) is the mainstay of treatment for visceral leishmaniasis (VL) or kala...
<p>Protein concentrations of 5ng/100μl rKLO8 or rK39 were tested with sera of patients and controls ...
International audienceDiagnostic tests for visceral leishmaniasis that are based on antigens of a si...
Diagnostic tests for visceral leishmaniasis that are based on antigens of a single Leishmania strain...
<p>Box plots (Tukey) for (A) IFN-γ, (B) TNF-α and (C) IL-10 responses in peripheral whole blood cell...
Pathogenesis in kala-azar is associated with depressed cellular immunity and significant elevation o...
Visceral leishmaniasis (VL) is considered as a major health threat in the Indian subcontinent. Leish...
Visceral leishmaniasis (VL) remains a major health problem in old world, and India accounts for half...
Visceral leishmaniasis (VL) remains a major health problem in old world, and India accounts for half...
Post kala-azar dermal leishmaniasis (PKDL), a dermal sequel of visceral leishmaniasis presents with ...
<p>Sera from mucosal <i>Leishmania</i>sis (ML) (n = 53) and cutaneous <i>Leishmania</i>sis (CL) (n =...
<p>The mean IgG responses are shown with 95% CI, for 36 Indian (purple line with nodes) and 36 Sudan...
Background: Visceral leishmaniasis (VL), a widely distributed systemic disease caused by infection w...
levels in patients from different geographical regions, either due to variable antigenicity or immu...
<p>Indian and Sudanese plasma study populations used in comparative serology against <i>Leishmania d...
Sodium antimony gluconate (SAG) is the mainstay of treatment for visceral leishmaniasis (VL) or kala...
<p>Protein concentrations of 5ng/100μl rKLO8 or rK39 were tested with sera of patients and controls ...
International audienceDiagnostic tests for visceral leishmaniasis that are based on antigens of a si...
Diagnostic tests for visceral leishmaniasis that are based on antigens of a single Leishmania strain...
<p>Box plots (Tukey) for (A) IFN-γ, (B) TNF-α and (C) IL-10 responses in peripheral whole blood cell...
Pathogenesis in kala-azar is associated with depressed cellular immunity and significant elevation o...
Visceral leishmaniasis (VL) is considered as a major health threat in the Indian subcontinent. Leish...
Visceral leishmaniasis (VL) remains a major health problem in old world, and India accounts for half...
Visceral leishmaniasis (VL) remains a major health problem in old world, and India accounts for half...
Post kala-azar dermal leishmaniasis (PKDL), a dermal sequel of visceral leishmaniasis presents with ...
<p>Sera from mucosal <i>Leishmania</i>sis (ML) (n = 53) and cutaneous <i>Leishmania</i>sis (CL) (n =...